Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam vs Indomethacin in Ankylosing Spondylitis
NCT02183168Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2001
- Primary completion
- May 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of meloxicam in ankylosing spondylitis (AS), sponsored by Boehringer Ingelheim. Started Jul 2001; status: completed.
02
Drugs
meloxicam
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02183168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183168.